Navigation Links
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Date:2/26/2009

BLISS-52 and BLISS-76, the ongoing Phase 3 trials of LymphoStat-B (belimumab), are the largest clinical trials ever conducted in lupus patients. HGS expects to report the first Phase 3 data for LymphoStat-B in July 2009 from the BLISS-52 trial, with results from BLISS-76 anticipated in November 2009. LymphoStat-B is being developed by HGS and GSK under a co-development and commercialization agreement entered into in August 2006.

Darapladib: GSK Initiates Phase 3 Development Program

In December 2008, GSK initiated STABILITY, the first Phase 3 clinical trial to evaluate the efficacy and safety of treatment with the investigational Lp-PLA2 inhibitor darapladib to reduce the risk of cardiovascular events in men and women with chronic coronary heart disease. More than 15,000 patients will participate in STABILITY. Darapladib was discovered by GSK based on HGS technology. HGS will receive 10% royalties on worldwide sales if darapladib is commercialized, and has a 20% co-promotion option in North America and Europe.

Syncria(R): GSK Initiates Phase 3 Development; HGS to Receive $9 Million Milestone

In February 2009, GSK announced initiation of a Phase 3 clinical trial program to evaluate the efficacy, safety and tolerability of Syncria (albiglutide) in the long-term treatment of type 2 diabetes mellitus. Syncria is a novel long-acting form of GLP-1 (glucagon-like peptide 1) created by HGS using its proprietary albumin-fusion technology, and licensed to GSK in 2004. HGS is entitled to fees and milestone payments that could amount to as much as $183 million - including $24 million received to date and an additional $9 million milestone payment to be received in the first quarter of 2009. HGS is also entitled to single-digit royalties on worldwide sales if Syncria is commercialized.

CONFERENCE CALL

HGS management
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
3. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
4. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
5. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
6. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
7. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
10. 2008 Human Research Protection Award Recipients Announced
11. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2015 Click here for additional information on ... DPLO ), the nation,s largest independent specialty pharmacy, ... 31, 2014. All comparisons, unless otherwise noted, are to the ... Fourth Quarter 2014 Highlights include: , Revenue of ... dispensed of 208,000, an increase of 11% , Gross ...
(Date:3/2/2015)... , March 2, 2015  Vivex Biomedical, Inc., a ... and biocellular products, announced today that it hired ... of UMTB Biomedical, Inc.   Vivex Biomedical formed UMTB Biomedical ... Miami Tissue Bank (UMTB) in November 2014. UMTB is ... Mr. Barnes is a twenty-five year veteran of the ...
(Date:3/2/2015)... March 2, 2015  Champions Oncology, Inc. (OTC-PINK: CSBR), ... solutions and services to personalize the development and use ... on the $2 million convertible promissory notes with two ... Dr. David Sidransky , chairman ... benefit from the confidence and commitment of our two ...
Breaking Medicine Technology:Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 19Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 20Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 21Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3
(Date:3/2/2015)... March 02, 2015 “ Wants and ... its monthly AppWatch, which features the latest and coolest ... Andrew Tropeano, a mobile technology expert and host of ... how this app helps people evaluate priorities. , Whether ... the Wants and Needs app. The app allows people ...
(Date:3/2/2015)... Raleigh, NC (PRWEB) March 02, 2015 ... response can be a better predictor of outcomes for ... here to read details of the new study ... and pathologists at the University of Eastern Piedmont followed ... underwent talc pleurodesis treatment for excess lung fluid. ...
(Date:3/2/2015)... Alabama (PRWEB) March 02, 2015 Robins ... - In conjunction with Women in Construction Week (March ... Construction, or NAWIC) and National Women’s History Month, Robins ... commitment positively affect the company and the construction industry ... management team, to the dozens of roles in between, ...
(Date:3/2/2015)... York (PRWEB) March 02, 2015 ... at Recovery Unplugged™—will be delivering a plenary address ... Perspective on the Art of Healing and Recovery ... (NCAD) and Behavioral Healthcare Executive Summit (BHES).     , ... Mr. Supa’s songs have been recorded by some ...
(Date:3/2/2015)... Mountain View, CA (PRWEB) March 02, 2015 ... announced today that it has officially launched a ... Bo Gustafsson, head of product development for BNatrl, ... developed through feedback from Olympic and other world-class ... I'm excited to use this pure whole food ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
... Start-up FundingMINNEAPOLIS, May 4 CoreSpine Technologies, a ... received 510(k) clearance to market from the U.S. ... Nucleus Removal System. "The clearance of the ... CoreSpine," said Christine Horton, Chief Executive Officer of ...
... wellness & HR summit for organizations in SE ... decision makers and HR professionals. Increase wellness, decrease ... productivity. TROY, Mich., May 4 Cambridge Employee ... host its fourth annual corporate Wellness & HR ...
... Group, a life science-focused strategic communications agency, announced today ... sciences agency client roster.Donna L. LaVoie, President & CEO ... working on the leading edge of the life sciences ... therapeutics for complex central nervous system disorders, Mithridion,s strategy ...
... Information from American Red CrossCHICAGO, May 4 As ... to the swine flu (H1N1 flu outbreak), millions of ... caregiver options. In response to this recent flu ... to Sittercity.com for the month of May. With ...
... members and 18 foreign associates from 15 countries elected recently to the ... ... CA (Vocus) May 4, 2009 -- Five UCSF faculty scientists ... countries elected recently to the National Academy of Sciences, the Academy has ...
... attention to urgency in preventing stroke and supporting 6 million stroke survivors ... ... year nearly 795,000 people will have a stroke, leaving a path of ... National Stroke Association , which is observing National Stroke Awareness Month ...
Cached Medicine News:Health News:CoreSpine Technologies(TM) Receives Clearance to Market Surgical Disc Preparation Device 2Health News:Cambridge Employee Benefits to Host Corporate Wellness & HR Summit 2Health News:LaVoie Group Appointed by Mithridion as PR Agency 2Health News:In-Home Caregivers Standing by Nationwide to Support Increased Need Due to Swine Flu 2Health News:Five UCSF Scientists Elected to National Academy of Sciences 2Health News:Five UCSF Scientists Elected to National Academy of Sciences 3Health News:Five UCSF Scientists Elected to National Academy of Sciences 4Health News:Five UCSF Scientists Elected to National Academy of Sciences 5Health News:Five UCSF Scientists Elected to National Academy of Sciences 6Health News:Five UCSF Scientists Elected to National Academy of Sciences 7Health News:Five UCSF Scientists Elected to National Academy of Sciences 8Health News:Four of Five Families Will Be Touched by Stroke in 2009 2
Inquire...
Inquire...
... Power Assisted Lipoplasty Device uses a 2-mm reciprocating ... the movement of the cannula in tissue. So ... more fibrous tissue. That makes the lipoplasty procedure ... ease your mind to learn that the PAL® ...
... level. Incredibly quiet, yet very powerful. Attachment ... at one time eliminates the need to ... canister set-up is for Abbott 2000ml system ... and CE marks. Includes a wireless foot-switch. ...
Medicine Products: